Hemorrhagic duodenal ulcer disease: Clinical and biochemical findings in a case-control pilot study
Current Therapeutic Research, ISSN: 0011-393X, Vol: 54, Issue: 5, Page: 494-499
1993
- 1Citations
- 6Captures
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations1
- Citation Indexes1
- CrossRef1
- Captures6
- Readers6
Article Description
A retrospective study of 31 consecutive bleeding duodenal ulcer (DU) patients and, as controls, 62 active DU subjects without bleeding episodes was conducted in order to ascertain whether bleeding DU patients have particular clinical or functional characteristics. The patients were followed for 15.6 and 17.4 months, respectively, after diagnosis. The following parameters were taken into account: sex, age, family history of ulcer, blood group (ABO system), ulcer pain, nonsteroidal anti-inflammatory drug (NSAID) consumption, cigarette smoking, alcohol and coffee consumption, ulcer site, fasting serum gastrin and pepsinogen group A, basal acid output (BAO), and maximal acid output (MAO). Statistics were gathered using the Student's t test and Fisher's exact test. Bleeding DU patients had less ulcer pain ( P < 0.005) and used more NSAIDs ( P < 0.05) than controls. All other clinical and functional data considered in both groups were comparable. Results showed that NSAID consumption was very dangerous in our DU patients even though bleeding episodes were observed. Usually no pain is felt immediately before hemorrhage, and cigarette smoking does not appear to affect this complication of DU.
Bibliographic Details
http://www.sciencedirect.com/science/article/pii/S0011393X0580668X; http://dx.doi.org/10.1016/s0011-393x(05)80668-x; http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=0027443596&origin=inward; http://linkinghub.elsevier.com/retrieve/pii/S0011393X0580668X; http://api.elsevier.com/content/article/PII:S0011393X0580668X?httpAccept=text/xml; http://api.elsevier.com/content/article/PII:S0011393X0580668X?httpAccept=text/plain; https://linkinghub.elsevier.com/retrieve/pii/S0011393X0580668X; https://api.elsevier.com/content/article/PII:S0011393X0580668X?httpAccept=text/xml; https://api.elsevier.com/content/article/PII:S0011393X0580668X?httpAccept=text/plain; http://dx.doi.org/10.1016/s0011-393x%2805%2980668-x; https://dx.doi.org/10.1016/s0011-393x%2805%2980668-x
Elsevier BV
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know